Skip to main content

CFO4Life Group, LLC

Position in NVS — Novartis AG

CIK 1706351 COPPELL, TX

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$770,435
+$5,158 QoQ
Shares Held
4,916
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#709
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. NVS ranks #3 (10.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVS
Novartis AG
This page
4,916 $770,435

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $770,435 4,916
2026-03-31 $765,277 5,010
2025-12-31 $787,099 5,709
2025-09-30 $730,583 5,697
2025-06-30 $671,726 5,551
2025-03-31 $667,653 5,989
2024-12-31 $644,094 6,619
2024-09-30 $717,724 6,240
2024-06-30 $567,644 5,332
2024-03-31 $619,652 6,406
2023-12-31 $708,304 7,015
2023-09-30 $728,400 7,151
2023-06-30 $632,201 6,265
2023-03-31 $528,264 5,742
2022-12-31 $582,513 6,421
2022-09-30 $422,311 5,556
2022-06-30 $462,632 5,473
2022-03-31 $494,208 5,632
2021-12-31 $509,775 5,828
2021-09-30 $505,563 6,182
2021-06-30 $531,746 5,828
2021-03-31 $500,228 5,852
2020-12-31 $534,473 5,660
2020-09-30 $492,193 5,660
2020-06-30 $513,908 5,884
2020-03-31 $479,611 5,817